Investor Stock List
Ranked #8,186 of 8,699 institutional investors

Versant Venture Management, LLC

San Francisco, CA

$88.6M
US stock portfolio at live prices · today −$1.6M (−1.82%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$109M
Change from Q2 2026
−$53.5M (−32.91%)
Positions
6 · 0 new, 0 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$8.5M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
GLUE 32.0%IPSC 18.1%JBIO 16.9%CTNM 13.2%LENZ 10.0%
StockSharesValue, live% of portfoliovs Q2 2026
GLUE Monte Rosa Therapeutics, Inc.3,180,780$28.3M32.0%Unchanged
IPSC Century Therapeutics, Inc.12,166,109$16.1M18.1%Unchanged
JBIO Jade Biosciences, Inc.991,783$14.9M16.9%Unchanged
CTNM Contineum Therapeutics, Inc.1,292,628$11.7M13.2%Added +138%
LENZ LENZ Therapeutics, Inc.2,656,888$8.9M10.0%Unchanged
SKYE Skye Bioscience, Inc.250,962$198K0.22%Unchanged